BBY
46
10
ES
34
3
SLB
55
2
SWK
64
5
SYK
64
-4
LH
43
-2
ACN
52
3
NRG
49
-3
COF
60
2
JPM
69
2
MA
64
7
INTU
56
-4
STI
14
-17
PGR
65
2
DE
63
3
SCHW
62
-2
DRI
53
5
PSA
58
2
DTE
56
2
CAH
48
-5
BBY
46
10
ES
34
3
SLB
55
2
SWK
64
5
SYK
64
-4
LH
43
-2
ACN
52
3
NRG
49
-3
COF
60
2
JPM
69
2
MA
64
7
INTU
56
-4
STI
14
-17
PGR
65
2
DE
63
3
SCHW
62
-2
DRI
53
5
PSA
58
2
DTE
56
2
CAH
48
-5
Financhill
Back

Arcutis Biotherapeutics Vs. Vertex Pharmaceuticals Industry Stock Comparison

Sell
26

ARQT
Arcutis Biotherapeutics

Last Price:
10.13
Seasonality Move:
101.78%
Sell
47

VRTX
Vertex Pharmaceuticals

Last Price:
450.53
Seasonality Move:
11.1%
Sell
26
Arcutis Biotherapeutics (ARQT) is a Sell

Is Arcutis Biotherapeutics a Buy, Sell or Hold?

  • The current Arcutis Biotherapeutics [ARQT] share price is $10.14. The Score for ARQT is 26, which is 48% below its historic median score of 50, and infers higher risk than normal.
  • ARQT is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
47
Vertex Pharmaceuticals (VRTX) is a Sell

Is Vertex Pharmaceuticals a Buy, Sell or Hold?

  • The current Vertex Pharmaceuticals [VRTX] share price is $450.97. The Score for VRTX is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
  • VRTX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

ARQT Stock Price Chart

What is Arcutis Biotherapeutics's stock price today?

  • The Arcutis Biotherapeutics share price today is $10.14
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ARQT is experiencing slight selling pressure.

VRTX Stock Price Chart

What is Vertex Pharmaceuticals's stock price today?

  • The Vertex Pharmaceuticals share price today is $450.97
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and VRTX is experiencing selling pressure, which indicates risk of future bearish movement.

ARQT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.21 Buy
Relative Strength Index (14 RSI): 55.7 Buy
Chaikin Money Flow: -485931 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (8.53 - 10.27) Buy
Bollinger Bands (100): (8.99 - 10.49) Buy

VRTX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -6.14 Sell
Relative Strength Index (14 RSI): 38.12 Sell
Chaikin Money Flow: -690526 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (459.98 - 494.52) Sell
Bollinger Bands (100): (464.62 - 492.24) Sell

ARQT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 9.97 Buy
20-day SMA: 9.64 Buy
50-day SMA: 9.59 Buy
200-day SMA: 9.5 Buy
8-day EMA: 10.03 Buy
20-day EMA: 9.79 Buy
50-day EMA: 9.65 Buy
200-day EMA: 9.16 Buy

VRTX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 463.98 Sell
20-day SMA: 477.93 Sell
50-day SMA: 473.88 Sell
200-day SMA: 453.97 Sell
8-day EMA: 461.92 Sell
20-day EMA: 472.05 Sell
50-day EMA: 474.74 Sell
200-day EMA: 452.65 Sell

Arcutis Biotherapeutics Earnings Growth & ARQT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.19 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.57 per share, and an increase next year of $0.41 per share.

Vertex Pharmaceuticals Earnings Growth & VRTX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.71 per share, a decrease next quarter of $0.00 per share, a decrease this year of $14.53 per share, and an increase next year of $18.25 per share.

Arcutis Biotherapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Vertex Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):